Establishing optimal cutoff values for high-sensitivity cardiac troponin algorithms in risk stratification of acute myocardial infarction

L Liu, K Lewandrowski - Critical Reviews in Clinical Laboratory …, 2024 - Taylor & Francis
Acute myocardial infarction (AMI) is a leading cause of mortality globally, highlighting the
need for timely and accurate diagnostic strategies. Cardiac troponin has been the biomarker …

Surface plasmon resonance biosensors for early troponin detection

F Ranjbari, A Nosrat, F Fathi, A Mohammadzadeh - Clinica Chimica Acta, 2024 - Elsevier
Acute myocardial infarction (AMI) is one of the life-threatening causes that decrease blood
flow to the heart, leading to increased mortality and related complications. Recently, the …

Cardiovascular diseases diagnosis using an ECG multi-band non-linear machine learning framework analysis

P Ribeiro, J Sá, D Paiva, PM Rodrigues - Bioengineering, 2024 - mdpi.com
Background: cardiovascular diseases (CVDs), which encompass heart and blood vessel
issues, stand as the leading cause of global mortality for many people. Methods: the present …

Optimal timing of percutaneous coronary intervention for non-ST elevated myocardial infarction with congestive heart failure

Y Lim, MC Kim, JH Ahn, SH Lee, DY Hyun… - Cardiovascular …, 2024 - Elsevier
Objectives This study investigated the optimal timing for percutaneous coronary intervention
(PCI) in patients with NSTEMI complicated by heart failure (HF). Methods In total, 762 …

Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia

S Béliard, S Saheb, S Litzler-Renault… - … and Vascular Biology, 2024 - Am Heart Assoc
BACKGROUND: Patients with homozygous familial hypercholesterolemia (HoFH) remain at
very high cardiovascular risk despite the best standard of care lipid-lowering treatment. The …

Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of …

T Bucci, F Del Sole, D Menichelli, G Galardo… - Journal of Clinical …, 2024 - mdpi.com
Objectives: To review the evidence on the effectiveness and safety of low-dose-rivaroxaban
2.5 mg twice daily (LDR) in patients with coronary artery disease (CAD) and/or peripheral …

Comparison between Invasive Intervention and Conservative Treatment in Patients with In-Hospital Myocardial Infarctions: Results from the Regional Myocardial …

M Assaf, D Costa, L Efremov, K Holland… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: In-hospital myocardial infarctions (AMIs) are less often treated with
invasive intervention, compared to out-of-hospital AMIs. We aimed to identify the …

Mixture of Doxycycline, ML-7 and L-NAME Restores the Pro-and Antioxidant Balance during Myocardial Infarction—In Vivo Pig Model Study

I Bil-Lula, W Kuliczkowski, A Krzywonos-Zawadzka… - Biomedicines, 2024 - mdpi.com
The restoration of blood flow to the ischemic myocardium inflicts ischemia/reperfusion (I/R)
heart injury (IRI). The main contributors to IRI are increased oxidative stress and subsequent …

A comprehensive guide on the optimal timing of PCI in the setting of acute coronary syndrome: An updated meta-analysis

A Abdelaziz, H Elsayed, K Atta, A Mechi… - International Journal of …, 2024 - Elsevier
Background Invasive revascularization is recommended for cohorts of patients with ST-
elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome …

The clinical significance of ischaemia-modified albumin in acute coronary syndrome and hypertension

G Pan, J Chen, C Lv, X Lin, J Huang, B Lin… - Cardiology in the …, 2024 - cambridge.org
Background: Early diagnosis of acute coronary syndrome is more and more important
because of its mortality and morbidity. Hypertension is one of the pathogenesis of acute …